Does ELTROMBOPAG OLAMINE Cause Decreased appetite? 188 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 188 reports of Decreased appetite have been filed in association with ELTROMBOPAG OLAMINE (ELTROMBOPAG). This represents 1.2% of all adverse event reports for ELTROMBOPAG OLAMINE.
188
Reports of Decreased appetite with ELTROMBOPAG OLAMINE
1.2%
of all ELTROMBOPAG OLAMINE reports
24
Deaths
69
Hospitalizations
How Dangerous Is Decreased appetite From ELTROMBOPAG OLAMINE?
Of the 188 reports, 24 (12.8%) resulted in death, 69 (36.7%) required hospitalization, and 9 (4.8%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for ELTROMBOPAG OLAMINE.
What Other Side Effects Does ELTROMBOPAG OLAMINE Cause?
Platelet count decreased (3,419)
Death (2,797)
Drug ineffective (1,117)
Platelet count increased (980)
Fatigue (868)
Headache (750)
Nausea (584)
Diarrhoea (558)
Product use in unapproved indication (545)
Malaise (516)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which ELTROMBOPAG OLAMINE Alternatives Have Lower Decreased appetite Risk?
ELTROMBOPAG OLAMINE vs ELUXADOLINE
ELTROMBOPAG OLAMINE vs ELVITEGRAVIR
ELTROMBOPAG OLAMINE vs EMAPALUMAB
ELTROMBOPAG OLAMINE vs EMAPALUMAB-LZSG
ELTROMBOPAG OLAMINE vs EMEND